Callable Multi Defender Vonti

Symbol: RMAXAV
ISIN: CH1427005017
Issuer:
Bank Vontobel
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Price Time-delayed price
24.08.26
15:15:05
72.00 %
- %
CHF
Volume
250,000
0
nominal
Trading hours for this product: 8:00 – 21:45

Performance

Closing prev. day 79.30
Diff. absolute / % -7.30 -9.21%

Determined prices

Last Price - Volume -
Time - Date -

More Product Information

Core Data

Name Callable Multi Defender Vonti
ISIN CH1427005017
Valor 142700501
Symbol RMAXAV
Quotation in percent Yes
Coupon p.a. 10.75%
Coupon Premium 10.75%
Coupon Yield 0.00%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached Yes (Novo Nordisk AS (B) - 26/02/2026)
Exercise type American
Currency Swiss Franc
First Trading Date 10/04/2025
Date of maturity 12/10/2026
Last trading day 05/10/2026
Settlement Type Path-dependent
IRS 871m Not applicable
Currency safeguarded Yes
Pricing Dirty
Issuer Bank Vontobel

Key data

Sideways yield p.a. -

market maker quality Date: 21/08/2026

Average Spread -
Last Best Bid Price 71.80 %
Last Best Ask Price - %
Last Best Bid Volume 100,000
Last Best Ask Volume 0
Average Buy Volume 0
Average Sell Volume 0
Average Buy Value 0 CHF
Average Sell Value 0 CHF
Spreads Availability Ratio 0.00%
Quote Availability 98.98%

Underlyings

Name Ypsomed Hldg. AG Novo Nordisk AS (B) Sandoz Group AG Roche PS
ISIN CH0019396990 DK0062498333 CH1243598427 CH1499059983
Price 408.60 CHF 40.3675 EUR 72.8800 CHF 369.30 CHF
Date 24/08/26 15:12 24/08/26 15:30 24/08/26 15:15 24/08/26 15:15
Cap 316.00 CHF 432.0000 DKK 33.0000 CHF 261.80 CHF
Distance to Cap 92.8 -131.15 40.1 109.4
Distance to Cap in % 22.70% -43.59% 54.86% 29.47%
Is Cap Level reached No No No No
Barrier 173.80 CHF 237.60 DKK 18.15 CHF 144.00 CHF
Distance to Barrier 235 10.7 54.95 227.2
Distance to Barrier in % 57.49% 4.31% 75.17% 61.21%
Is Barrier reached No Yes No No

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.